Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
The 12mg weekly arm produced a 24.2% mean body weight reduction over 48 weeks, with 26% of participants achieving at least 30% total body weight loss a threshold previously unattained by any pharmacological intervention in a clinical trial setting
No medical, clinical, therapeutic, cosmetic, veterinary, dietary, wellness, performance, recovery, injury, or personal-use claims are made for this product
Ongoing surveillance is only recommended if extensive gastric atrophy, intestinal metaplasia, or additional risk factors are identified
After carefully evaluating the options, we chose subcutaneous NAD+ injections as the best balance of effectiveness, affordability, and convenience for our clients
The exceptions are the ones that went through the full pharmaceutical pipeline: insulin, GLP-1 drugs like semaglutide, and a handful of others
Injections are preferred for addressing inflammation, muscle sprains, ligament damage, and pain
US$ 21.25
US$ 29.21
US$ 26.96
US$ 24.86
US$ 23.15